Two cases of somatostatin-producing ampullary neuroendocrine tumors (somatostatinoma) are reported. The authors have characterized their immunoreactivity using antibodies specific for the amino- and carboxyl-terminal portions of prosomatostatin, the precursor of somatostatin in the normal synthetic pathway. Cytoplasmic staining was found using each of these two antibodies in the tumor cells of both ampullary somatostatinomas as well as in the cytoplasm of cells in the hypothalamus, crypt cells of the duodenal mucosa, mucosal cells of the biliary tract, D cells of the pancreatic islets, and parafollicular cells of fetal thyroid. These studies suggest that the synthesis of somatostatin in ampullary somatostatinomas occurs through the normal pathway from the precursor prosomatostatin.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/ajcp/97.3.411 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Somatostatinoma Presented as Double-Duct Sign.
Case Rep Gastrointest Med
May 2019
Division of Gastroenterology, Providence-Providence Park Hospital and Medical Center, Michigan State University/College of Human Medicine, Southfield, Michigan, USA.
Somatostatinoma is a rare neuroendocrine tumor with an incidence rate of 1 in 40 million people. It presents mostly as asymptomatic tumor diagnosed incidentally on imaging or surgery when evaluating or treating possible causes of abdominal pain. It also can present with vague symptoms, or as a clinical triad of glucose intolerance, steatorrhea, and achlorhydria.
View Article and Find Full Text PDFA Transgenic Mouse Model of Pacak⁻Zhuang Syndrome with An Gain-of-Function Mutation.
Cancers (Basel)
May 2019
Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Article Synopsis
- A novel syndrome was identified in patients featuring paraganglioma, somatostatinoma, and polycythemia, with polycythemia appearing prior to any tumor formation.
- Genetic mutations affecting HIF2α were determined to be the underlying cause, prompting research to confirm their role in the syndrome's symptoms.
- Transgenic mice with these mutations showed increased erythropoietin levels and continued polycythemia even after treatment with a HIF2α inhibitor, indicating other mechanisms at play and highlighting the potential for this model in studying the syndrome's pathogenesis and treatment.
Duodenal somatostatinoma presenting as obstructive jaundice with the coexistence of a gastrointestinal stromal tumour in neurofibromatosis type 1: a case with review of the literature.
BMJ Case Rep
January 2019
Division of Endocrinology, Department of Internal Medicine, Texas Tech University Health Science Center School of Medicine, Lubbock, Texas, USA.
Somatostatinomas are rare neuroendocrine tumours, mostly located in the pancreas or duodenum, with an estimated incidence of 1 in 40 million. Duodenal somatostatinomas (DSs) are usually found in association with neurofibromatosis type 1 (NF1), tuberous sclerosis and Von Hippel-Lindau syndrome. Gastrointestinal stromal tumours (GIST) have also been described in NF1, but the association with somatostatinoma is very uncommon.
View Article and Find Full Text PDFThe Coexistence of Somatostatinoma and Gastrointestinal Stromal Tumor in the Duodenum of a Patient with Von Recklinghausen's Disease.
Intern Med
September 2016
Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Japan.
We herein describe a case of somatostatinoma coexisting with a gastrointestinal stromal tumor (GIST) in the duodenum of an 81-year-old woman with Von Recklinghausen's disease (VRD) and common bile duct stone who presented with diarrhea of three months in duration. Gastroduodenoscopy revealed an ulcer on the second part of the duodenum. A 2.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!